Pharming Group N.V./€PHARM

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Pharming Group N.V.

Pharming Group N.V. is a biotechnology company based in Leiden, Netherlands, focused on developing and commercializing innovative protein replacement therapies and precision medicines. The company's primary product, Ruconest, is an approved treatment for acute hereditary angioedema attacks, utilizing a recombinant form of the C1 esterase inhibitor. Established in 1988, Pharming leverages proprietary transgenic technology to produce human therapeutic proteins in the milk of genetically modified animals. With a strategic emphasis on rare diseases, the company aims to expand its pipeline through ongoing research and development activities. Pharming operates primarily in Europe and the United States, with partnerships and collaborations enhancing its global presence.

Ticker

€PHARM

Sector

Health

Primary listing

AEX

Employees

404

PHARM Metrics

BasicAdvanced
€721M
-
-€0.01
0.54
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €PHARM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs